Latest Breaking News On - சாதனம் குரு கோப்பு - Page 1 : comparemela.com
One Day Online Seminar on Understanding Latin America s
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
ComplianceOnline Hosts Seminar on The Latin America Regulatory Compliance Requirements for the Life Science Industry
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
25 febbraio 2021 08:38
Fonte: Adnkronos
#chimica-e-farmacia
TOKYO, Feb. 25, 2021 /PRNewswire/ The Polyplastics Group is expanding its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.
(Image1: https://kyodonewsprwire.jp/prwfile/release/M100475/202102221287/ prw PI1fl gB42P6Vy.jpeg)
(Image2: https://kyodonewsprwire.jp/prwfile/release/M100475/202102221287/ prw PI2fl gNFyh258.jpeg)
Polyplastics PM series, which also includes DURACON PM09S01N, a standard viscosity grade, complements the company s TOPAS (R) cyclic olefin copolymer (COC) product, a high-purity material for a range of medical applications.
Polyplastics Expands DURACON (R) POM PM Series with New High-flow Grade for Medical and Healthcare Industry
asiaone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaone.com Daily Mail and Mail on Sunday newspapers.
Skip to main content
Currently Reading
Cirtec completes Device Master File (MAF) for their recent acquisition of the Nuvectra Algovita Spinal Cord Stimulation System
PRWeb
FacebookTwitterEmail
MINNEAPOLIS (PRWEB) February 01, 2021
Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices including active implantables, minimally invasive devices and novel catheter-based delivery systems, today announced a sponsor-initiated withdrawal of the premarket approval (PMA) for the Nuvectra Algovita Spinal Cord Stimulation System. The System was an FDA and CE Mark approved neurostimulation system with no open field actions at the time of acquisition. The withdrawal of the PMA and subsequent creation of the Device Master File aligns with Cirtec’s strategy to support Academic, Research and Commercial partners with design, development, and manufacturing of active implantable device.